Dr. Elman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9114 Philadelphia Rd
Ste 310
Baltimore, MD 21237Phone+1 410-686-3394Fax+1 410-686-3394
Summary
- Dr. Michael Elman is an ophthalmologist in Rosedale, MD and is affiliated with multiple hospitals in the area, including MedStar Franklin Square Medical Center, Greater Baltimore Medical Center, and Sinai Hospital of Baltimore. He received his medical degree from Wayne State University School of Medicine and has been in practice 38 years. He also speaks multiple languages, including Hebrew. He specializes in retinal disease and is experienced in diabetic retinopathy, macular edema, ocular trauma, central retinal vein occlusion, and vitreoretinal disease.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1984 - 1985
Johns Hopkins UniversityResidency, Ophthalmology, 1983 - 1984
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1980 - 1983
Detroit Medical Center/Wayne State UniversityInternship, Internal Medicine, 1979 - 1980
Wayne State University School of MedicineClass of 1979
Certifications & Licensure
MD State Medical License 1985 - 2026- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 811 citationsLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trialEmily Y. Chew, Traci E Clemons, John Paul SanGiovanni, Ronald P. Danis, Frederick L. Ferris
JAMA. 2013-05-15 - 35 citationsOral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David S. Boyer, David M. Brown, Nauman A Chaudhry, Michael J. Elman
JAMA Ophthalmology. 2017-07-01 - 141 citationsSubretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments TrialsAlex S. Willoughby, Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell Burns
Ophthalmology. 2015-09-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
